The effect of non-alcoholic fatty liver disease on pregnancy and neonatal outcomes: literature review
Abstract
At present, non-alcoholic fatty liver disease (NAFLD) is one of the most widespread chronic liver diseases among the adult population. The number of patients with this diagnosis continues to increase in parallel with the rising prevalence of obesity. Pregnant women are no exception and are also affected by this disease, with its incidence continuing to grow. NAFLD is one of the risk factors for the development of diseases and complications affecting both the mother and the fetus during this period of a woman’s life. This review article provides information about the most common and potential predictors of such complications. Undoubtedly, further studies of current markers, as well as the search for new ones associated with a higher risk of pregnancy complications in women with NAFLD, are required.
References
Clinical guidelines. Non-alcoholic fatty liver disease. 2024.
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402. DOI: 10.1016/j.jhep.2015.11.004.
Rinella Mary E., Lazarus Jeffrey V., Ratziu Vlad et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6): 1966–1986. DOI: 10.1097/HEP.0000000000000520.
Hamza El Hadi et al. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. 2019. DOI: 10.3390/ijms20092215.
Евстифеева С.Е., Шальнова С.А., Куценко В.А., Яровая Е.Б., Баланова Ю.А., Имаева А.Э. и др. Распространенность неалкогольной жировой болезни печени среди населения трудоспособного возраста: ассоциации с социально-демографическими показателями и поведенческими факторами риска (данные ЭССЕ-РФ-2). Кардиоваскулярная терапия и профилактика. 2022;21(9):3356. DOI: 10.15829/1728-8800-2022-3356.
Rinella M.E., Neuschwander-Tetri B.A., Siddiqui M.S., Abdelmalek M.F., Caldwell S., Barb D., Kleiner D.E., Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797–1835. DOI: 10.1097/HEP.0000000000000323.
Seung Mi Lee et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus, Diabetologia. 2019;62:238–248. DOI: 10.1007/s00125-018-4779-8.
Ивашкин В.Т., Жаркова М.С., Корочанская Н.В., Хлынов И.Б., Успенский Ю.П. Фенотипы неалкогольной жировой болезни печени в различных регионах Российской Федерации, диагностические и лечебные подходы в клинической практике. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2023;33(2):7–18. DOI: 10.22416/1382-4376-2023-33-2-7-18.
Lee J.Y. et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. J Hepatol. 2007;47:239–244. DOI: 10.1016/j.jhep.2007.02.007.
Nádasdi Á., Somogyi A., Igaz P., Firneisz G. Nem alkoholos zsírmájbetegség — a 2016. évi közös EASL-EASD-EASO klinikai ajánlás fényében [Non-alcoholic fatty liver disease — a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016]. Orv Hetil. 2018;159(45):1815–1830. (In Hungarian). DOI: 10.1556/650.2018.31231.
Ha Y. et al. Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study. J Gastroenterol Hepatol. 2015;30:1666–1672. DOI: 10.1111/jgh.12996.
Ko Y.H. et al. The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord. 2017;15:304–311. DOI: 10.1089/met.2017.0001.
Omagari K. et al. Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. J Gastroenterol Hepatol. 2002;17:1098–1105. DOI: 10.1046/j.1440-1746.2002.02846.x.
Lee S.M., Kim W. Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time? Clin Mol Hepatol. 2022;28(1):47–49. DOI: 10.3350/cmh.2021.0338.
Yiğit Berk Şahin et al. Pregnancy & Liver Diseases. World gastroenterology news. 2025;30(1).
Monika Sarka et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020;73(3):516–522. DOI: 10.1016/j.jhep.2020.03.049.
Yiling Qian et al. Nonalcoholic Fatty Liver Disease and Adverse Pregnancy Outcomes in Women With Normal Prepregnant Weight. J Clin Endocrinol Metab. 2023;108(2):463–471. DOI: 10.1210/clinem/dgac567.
Razieh Mohammad Jafari et al. Pregnancy outcome in patients with non-alcoholic fatty liver disease: a prospective cohort study. Gastroenterol Hepatol Bed Bench. 2024;17(2):180–186. DOI: 10.22037/ghfbb.v17i2.2896.
Lee S.M., Kim B.J., Koo J.N., Norwitz E.R., Oh I.H., Kim S.M., Kim S.Y., Kim G.M., Kwak S.H., Kim W., Joo S.K., Shin S., Vixa C., Park C.W., Jun J.K., Park J.S. Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. PLoS One. 2019;14(8): e0221400. DOI: 10.1371/journal.pone.0221400.
Jung Y.M., Lee S.M., Hong S., Koo J.N., Oh I.H., Kim B.J., Kim S.M., Kim S.Y., Kim G.M., Kyung Joo S., Shin S., Norwitz E.R., Park C.W., Jun J.K., Kim W., Park J.S. The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. Liver Int. 2020;40(10):2417–2426. DOI: 10.1111/liv.14563.
Hong S., Lee S.M., Kwak S.H., Kim B.J., Koo J.N., Oh I.H., Oh S., Kim S.M., Shin S., Kim W., Joo S.K., Norwitz E.R., Louangsenlath S., Park C.W., Jun J.K., Park J.S. A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus. Diabetes Metab J. 2020;44(5):726–736. DOI: 10.4093/dmj.2019.0126.
El Jamaly H., Eslick G.D., Weltman M. Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clin Mol Hepatol. 2022;28(1):52–66. DOI: 10.3350/cmh.2021.0205.
Lee S.M., Cho G.J., Wi W.Y. et al. Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study. Hepatol Int. 2023;17:367–376. DOI: 10.1007/s12072-022-10458-w.
Zhang L., Gao S., Luan Y., Su S., Zhang E., Liu J., Xie S., Zhang Y., Yue W., Liu R., Yin C. Predictivity of Hepatic Steatosis Index for Gestational Hypertension and Preeclampsia: a Prospective Cohort Study. Int J Med Sci. 2025;22(4):834–844. DOI: 10.7150/ijms.104943.
Ziqubu K., Dludla P.V., Mthembu SXH., Nkambule B., Mazibuko-Mbeje S.E. Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review. Adipocyte. 2024;13(1):2390833. DOI: 10.1080/21623945.2024.2390833.
Luo Q., Liu G., Li Q., Lu J., Zheng W., Huang Y., Li C. Novel insights into causal effects of maternal nonalcoholic fatty liver disease on adverse pregnancy outcomes: evidence from Human Genetics and Mendelian Randomization Study. Eur J Clin Nutr. 2024;78(12):1041–1050. DOI: 10.1038/s41430-024-01489-7.
Клинические рекомендации. Гестационный сахарный диабет. МЗ РФ. 2024.
Tiikkainen M., Tamminen M., Häkkinen A.-M., Bergholm R., Vehkavaara S., Halavaara J., Teramo K., Rissanen A., Yki-Järvinen H. MD. Liver-Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes. 2012. DOI: 10.1038/oby.2002.118.
Forbes S., Taylor-Robinson S.D., Patel N., Allan P., Walker B.R., Johnston D.G. Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia. 2011;54:641–647.
El. Jamaly H., Eslick G.D., Weltman M. Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clin Mol Hepatol. 2022;28(1):52–66. DOI: 10.3350/cmh.2021.0205.
Qian-Ren Zhang et al. Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease, Hepatobiliary Pancreat Dis Int. 2025;24(2):128–137. DOI: 10.1016/j.hbpd.2023.12.007.
Jessica Tyrrell et al. Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight, JAMA. 2016;315(11):1129–40. DOI: 10.1001/jama.2016.1975.
Zhang B., Zhan Z., Xi S., Zhang Y., Yuan X. Association Between Maternal Creatinine to Body Weight Ratio and Small/Large for Gestational Age Newborns Among 11,734 Chinese Women. J Epidemiol Glob Health. 2025;15(1):70. DOI: 10.1007/s44197-025-00414-w.
Metzger B.E., Coustan D.R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(2):B161–7.
Hannes Hagström et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liv Int. 2016;36(2):268–274. DOI: 10.1111/liv.12902.
Page L.M., Girling J.C. A novel cause for abnormal liver function tests in pregnancy and the puerperium: non-alcoholic fatty liver disease. BJOG. 2011;118(12):1532-5. DOI: 10.1111/j.1471-0528.2011.03070.x.
Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. DOI: 10.1002/hep.28431.
Niu C., Zhang J., Khalid N., Zhu K., Syed T., Liu H., Okolo PI 3rd. Cardiovascular complications during delivery hospitalizations in patients with nonalcoholic fatty liver disease in pregnancy. Eur J Gastroenterol Hepatol. 2024;36(9):1141–1148. DOI: 10.1097/MEG.0000000000002802.
Lee S.M., Kim W. Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time? Clin Mol Hepatol. 2022;28(1):47–49. DOI: 10.3350/cmh.2021.0338.
Ballestri S., Zona S., Targher G., Romagnoli D., Baldelli E., Nascimbeni F. et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:936–944.
Barker D.J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49(2):270–83. DOI: 10.1097/00003081-200606000-00009.
Iresha Sandamali Koralegedara et al. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages — prospective study in Rajarata Pregnancy Cohort (RaPCo), BMJ Open Gastroenterol. 2022;9(1):e000831. DOI: 10.1136/bmjgast-2021-000831.
Metwally Mostafa et al. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008;90(3):714–726.
Alfredo M. Germain et al. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol. 2003;189(2):577–582. DOI: 10.1067/S0002-9378(03)00545-3.
Aliza Gross et al. Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy. Eur J Pediat. 2023;182:3765–3774. DOI: 10.1007/s00431-023-05044-7.
Bril F., Barb D., Portillo-Sanchez P., Biernacki D., Lomonaco R., Suman A. et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology. 2017;65:1132–1144.
Loomba R., Friedman S.L., Shulman G.I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537–64.
Zhang Y., Bu Y., Zhao R., Han C. Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives. Ther Adv Endocrinol Metab. 2024;15:20420188241274350. DOI: 10.1177/20420188241274350.
Yang J., Shrestha A., Ramalingam L. Fishing for Solutions: How Pre-Conceptional Fish Oil Supplementation in Obese Fathers Reduces Risk of Non-Alcoholic Fatty Liver Disease in Offspring Mice. Mol Nutr Food Res. 2025;69(5):e202400452. DOI: 10.1002/mnfr.202400452.
Успенский Ю.П., Балукова Е.В. Неалкогольная жировая болезнь печени: современные перспективы терапии. Медицинский алфавит. Практическая гастроэнтерология. 2017;27(3).
Успенский Ю.П., Фоминых Ю.А., Кацына А.Р. и др. Клинический случай лекарственного поражения печени. University Therapeutic Journal. 2025;7(1):190–197. DOI: 10.56871/UTJ.2025.87.23.017.
